UFC

Crinetics Announces Positive Initial Findings at ENDO 2024 for Atumelnant in Two Ongoing, Open-Label Studies for the Treatment of Congenital Adrenal Hyperplasia (CAH) and ACTH-Dependent Cushing’s Syndrome (ADCS)

Retrieved on: 
måndag, juni 3, 2024
ENDO, Aes, Headache, A4, Fatigue, Diabetes, Endocrine system, CAH, ULN, Glucocorticoid, Safety, SAN, UFC, ACTH, Cohort, Upper respiratory tract infection, Single Center, Abstract, Food, Human, ADCS, University College Hospital, Congenital adrenal hyperplasia, Endocrinology, Bangladesh Technical Education Board, 24 Hours, Pharmaceutical industry

SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced initial findings from the development program of its second clinical product candidate, atumelnant* (CRN04894), a novel, once-daily oral adrenocorticotropic hormone (ACTH) receptor antagonist. The results, presented at the Endocrine Society’s annual meeting (ENDO2024), include initial data from the Phase 1b/2a, open-label study in participants with ACTH-dependent Cushing’s syndrome (ADCS) conducted in collaboration with the National Institutes of Health, and the Phase 2 open-label TouCAHn study in participants with congenital adrenal hyperplasia (CAH).

Key Points: 
  • The trial continues to enroll three treatment cohorts: 80 mg once daily (n=9), 40 mg once daily (n=9) and 120 mg once daily (n=6).
  • Available data for 80 mg includes: n=4 at 12 weeks of treatment, with two additional participant’s data up to six weeks of treatment.
  • The TouCAHn study is ongoing, with topline results from the complete study expected in the second half of 2024.
  • Crinetics will host an investor conference call on June 3, 2024, at 4:30 pm Eastern Time to discuss the initial findings from these two studies.

Conor McGregor and Virat Kohli Collaborate to Launch TIDL's Innovative Pain Relief Products in India

Retrieved on: 
måndag, juni 3, 2024
Chronic pain, No Limits, Prashant Raj, Health, Mental health, Walmart, Sleep, Sensation, Family, UFC, T20, Athlete, Quality of life, Conor, CVS, Entrepreneurship, Baidyanath Temple, Partnership, Target

This extraordinary milestone heralds a new era in pain relief, driven by the company’s unwavering commitment to innovation and excellence.

Key Points: 
  • This extraordinary milestone heralds a new era in pain relief, driven by the company’s unwavering commitment to innovation and excellence.
  • Partnering with Virat Kohli to bring our cutting-edge products to India is a thrill for both of us.
  • No Pain, No Limits!”
    Prashant Raj, Partner and Director of India for TIDL, highlighted the significance of this launch: “Bringing TIDL to India is a landmark achievement.
  • The brand’s expansion into India is poised to transform the pain relief market, providing unparalleled access to premium products that truly make a difference.

Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024

Retrieved on: 
måndag, juni 3, 2024
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, ENDO, ITT, Aes, Group 2, Quantile, Patient, ULN, Doctor of Pharmacy, Publication, UFC, Female, Group 3, Incidence, Disease, Group 1, ALT, GGT

This exploratory analysis brings further perspective to the importance of individualizing and tailoring medical management,” said James Meyer, PharmD, Xeris’ Senior Director, Publications and Medical Communications.

Key Points: 
  • This exploratory analysis brings further perspective to the importance of individualizing and tailoring medical management,” said James Meyer, PharmD, Xeris’ Senior Director, Publications and Medical Communications.
  • Daily doses of levoketoconazole were related to baseline mUFC.
  • Group 3 had a higher incidence of liver test (ALT, AST, GGT) abnormalities compared to Group 1 and Group 2.
  • This post hoc analysis demonstrated:
    Normalization of mUFC with levoketoconazole in Cushing’s syndrome patients maintained on levoketoconazole in the SONICS study for up to 6 months appeared to vary inversely with baseline mUFC.

UFC and Aires Tech Announce Multi-Year Global Marketing Partnership

Retrieved on: 
torsdag, maj 30, 2024
Partnership, Athlete, EMF, Electromagnetic radiation, Sport, Prudential Center, TKO, Health, Official, WME, EMR, Growth, Pay-per-view, UFC, Future

Las Vegas, Nevada--(Newsfile Corp. - May 30, 2024) - UFC®, the world's premier mixed martial arts organization, and American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) (Aires Tech or Aires), a pioneer in cutting-edge technology designed to protect against electromagnetic radiation and optimize human health, today announced a new global marketing partnership that will showcase Aires Tech branding within UFC's biggest events.

Key Points: 
  • Las Vegas, Nevada--(Newsfile Corp. - May 30, 2024) - UFC®, the world's premier mixed martial arts organization, and American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) (Aires Tech or Aires), a pioneer in cutting-edge technology designed to protect against electromagnetic radiation and optimize human health, today announced a new global marketing partnership that will showcase Aires Tech branding within UFC's biggest events.
  • "We're thrilled to welcome Aires Tech as an official UFC partner," said Grant Norris-Jones, Head of Global Partnerships at TKO.
  • American Aires CEO, Josh Bruni, commented: "I am delighted to announce this transformative partnership with UFC, an organization renowned for its innovative approach and commitment to excellence in sports entertainment.
  • This partnership with UFC builds on Aires Tech support for world-class athletes who want to safeguard themselves from excessive electromagnetic radiation (EMR).

American Aires Announces Q1 2024 Results with Strong 37% YoY Sales Growth Despite Traditionally Soft Q1 Consumer Spending

Retrieved on: 
tisdag, maj 28, 2024
Mass media, Conversation, Yoy, NFL, Endeavor (company), Investment, Electromagnetic radiation, Management, Health, Marketing, WME, Financial statement, Rumble, MD, Growth, OTC, Advertising, POP, QB, Russell Brand, UFC

Quarterly performance was in line with Aires management’s expectations, with a strong 37% YoY increase in sales despite expected Q1 consumer spending weakness due to Q4’s traditionally increased seasonal purchases.

Key Points: 
  • Quarterly performance was in line with Aires management’s expectations, with a strong 37% YoY increase in sales despite expected Q1 consumer spending weakness due to Q4’s traditionally increased seasonal purchases.
  • Management also notes that order volume growth has materially increased in April 2024 to 47% YoY and to date in May 2024 to 132% YoY.
  • Subsequent to Q1 2024, the Company further strengthened its treasury by closing a financing in 2 tranches in May 2024 for gross proceeds of $3,770,465 to Aires.
  • The Aires stock price trended up strongly throughout Q1 2024, rising from $0.20 on January 2nd to $0.95 as of May 28, 2024.

HotelPlanner Welcomes UFC Fighter Colby Covington as Brand Ambassador

Retrieved on: 
tisdag, maj 28, 2024
Partnership, Oregon State University, Chaos, PALM, Colby Covington, Social media, UFC, Ultimate, Erosion (morphology)

As a brand ambassador, Colby will give away $5,000 in HotelPlanner free hotel booking credit to one of his fans through his social media during his fights.

Key Points: 
  • As a brand ambassador, Colby will give away $5,000 in HotelPlanner free hotel booking credit to one of his fans through his social media during his fights.
  • Just like I take care of business in the octagon, HotelPlanner gets you the best deals on hotels,” says Colby Covington.
  • "We're absolutely thrilled to welcome Colby Covington to the HotelPlanner family as our brand ambassador," says HotelPlanner CEO and co-founder, Tim Hentschel.
  • We believe this partnership will be a game-changer, and we look forward to working with Colby to elevate the HotelPlanner brand and connect with travelers around the world."

TKO Merges UFC® and WWE® Live Events Groups

Retrieved on: 
torsdag, maj 23, 2024
Sports, Martial Arts, Extreme Sports, Boxing, Licensing (Entertainment), Events, Concerts, Wrestling, Entertainment, House show, WrestleMania, Royal Rumble, WrestleMania XL, Tropicana Field, City, MMA, TKO, Sport, WWE, Elimination Chamber, Growth, Elimination, UFC, Operation, Tourism Western Australia, Management

TKO Group Holdings, Inc. (NYSE: TKO), a premium sports and entertainment company, today announced that it has integrated the UFC and WWE Live Events teams into one unit, creating one of the strongest live events portfolios in all of sports and entertainment.

Key Points: 
  • TKO Group Holdings, Inc. (NYSE: TKO), a premium sports and entertainment company, today announced that it has integrated the UFC and WWE Live Events teams into one unit, creating one of the strongest live events portfolios in all of sports and entertainment.
  • The integrated unit, the TKO Live Events Strategy Team, will drive revenue growth strategies across key areas, including live event development and scheduling, tourism incentive programs, ticketing, and fan experiences.
  • “Demand for live sports and entertainment has never been stronger, and we believe our portfolio of events will continue to drive the growth of our business,” said Andrew Schleimer, Chief Financial Officer, TKO.
  • WWE’s Premium Live Events in the quarter – Royal Rumble and Elimination Chamber – delivered record gross gate revenue.

Xtreme One Entertainment Teams With TrillerTV to Stream XFC Events for 8 Million+ Registered Users Worldwide

Retrieved on: 
torsdag, maj 9, 2024
CMO, MMA, Partnership, Smart TV, PFL, OTT, UFC, XFC, Veteran, Nightclub

“Building off the success of XFC50, we’re pleased to team up with TrillerTV and secure a broadcast agreement for the next year of XFC events,” said Doug Kuiper, President of Xtreme One Entertainment.

Key Points: 
  • “Building off the success of XFC50, we’re pleased to team up with TrillerTV and secure a broadcast agreement for the next year of XFC events,” said Doug Kuiper, President of Xtreme One Entertainment.
  • “Fans can watch TrillerTV from any device, anywhere, and the platform is a recognized leader in combat sports streaming.
  • TrillerTV and XFC are offering an early-purchase discount for XFC Grand Prix II of $19.99 if purchased by May 29, 2024, and then $24.99 following.
  • “XFC is a top MMA brand that features compelling fighters in their events,” said TrillerTV CMO Kim Hurwitz.

XFC Grand Prix II Fight Card to Feature Alex Nicholson vs Carl Seumanutafa, Pearl Gonzalez vs Rainn Guerrero, and Michigan’s Own Collin Anglin

Retrieved on: 
tisdag, maj 7, 2024
Hexagon, Courage, WAR, Michigan State University, MMA, VIP, American Top Team, Invicta, PFL, Athlete, Triller, Detroit Grand Prix, UFC, XFC, Xtreme Fighting Championships, Nightclub

They’ll be able to feel it all the way out to 8 Mile when these two square off inside The Hexagon.

Key Points: 
  • They’ll be able to feel it all the way out to 8 Mile when these two square off inside The Hexagon.
  • Pearl “The Chitown Princess” Gonzalez returns to XFC action fresh off her win at XFC 50.
  • XFC Grand Prix II will also feature Michigan-based and Michigan State University alum Collin Anglin, who has competed in UFC and is sure to earn hometown fanfare.
  • Fans can purchase tickets for XFC Grand Prix II at XFCFight.com or at The Masonic Temple box office.

Urbanfund Corp. Announces Loan to Shareholder

Retrieved on: 
tisdag, maj 7, 2024
UFC, Mitchell Cohen, Security (finance)

TORONTO, May 07, 2024 (GLOBE NEWSWIRE) -- Urbanfund Corp. (TSX-V: UFC) (“Urbanfund” or the “Company”), announces that it entered into loan agreement dated May 7, 2024 (the “Loan Agreement”) pursuant to which the Company has agreed to loan Westdale Construction Co. Limited (“Westdale”) the principal amount of ‎‎$6,000,000‎‎ (the “Loan”).

Key Points: 
  • TORONTO, May 07, 2024 (GLOBE NEWSWIRE) -- Urbanfund Corp. (TSX-V: UFC) (“Urbanfund” or the “Company”), announces that it entered into loan agreement dated May 7, 2024 (the “Loan Agreement”) pursuant to which the Company has agreed to loan Westdale Construction Co. Limited (“Westdale”) the principal amount of ‎‎$6,000,000‎‎ (the “Loan”).
  • The Loan is repayable within three months and will bear interest at ‎‎8.2% per annum.
  • The Loan is exempt from the formal valuation and minority shareholder approval requirements of 61-101.
  • The Loan is further exempt from the minority shareholder approval requirement pursuant to section 5.7(1)(a) of MI 61-101 as the fair market value of Loan is less than 25% of the Company’s market capitalization.